John Price

Detailed protocol for optimised expression and purification of functional monomeric human Heat Shock Factor 1

Joseph Polidano, Naveen Vankadari, John T Price, Jacqueline A Wilce

Journal article  |  2020  |  Protein Expression and Purification

Peer Connect Service for people with pulmonary fibrosis in Australia: Participants' experiences and process evaluation

Gabriella Tikellis, Joanna YT Lee, Tamera J Corte, Jamie Maloney, Michael Bartlett, Tonia Crawford, Ian N Glaspole, Nicole Goh, Kelcie Herrmann, Alison J Hey-Cunningham, Greg Keir, Yet H Khor, John Price, Debra G Sandford, Lissa Spencer, Alan Teoh, Jennifer Walsh, Susanne Webster, Anne E Holland

Journal article  |  2020  |  Respirology

BACKGROUND AND OBJECTIVE: People living with pulmonary fibrosis (PF) report unmet needs for information and support. Lung Foundati..

The importance of developing therapies targeting the biological spectrum of metastatic disease

Andries Zijlstra, Ariana Von Lersner, Dihua Yu, Lucia Borrello, Madeleine Oudin, Yibin Kang, Erik Sahai, Barbara Fingleton, Ulrike Stein, Thomas R Cox, John T Price, Yasumasa Kato, Alana L Welm, Julio A Aguirre-Ghiso

Journal article  |  2019  |  Clinical & Experimental Metastasis

Netrin-1-like-immunoreactivity Coexpresses With DCC and Has a Differential Level in the Myenteric Cholinergic and Nitrergic Neurons of the Adult Mouse Colon

Suh Youn Ko, John T Price, Gregory L Blatch, Kulmira Nurgali

Journal article  |  2019  |  Journal of Histochemistry & Cytochemistry

Heat shock proteins as modulators and therapeutic targets of chronic disease: an integrated perspective

Adrienne L Edkins, John T Price, A Graham Pockley, Gregory L Blatch

Journal article  |  2018  |  Philosophical Transactions of the Royal Society B Biological Sciences

Melphalan modifies the bone microenvironment by enhancing osteoclast formation

Ryan C Chai, Michelle M McDonald, Rachael L Terry, Natasa Kovacic, Jenny M Down, Jessica A Pettitt, Sindhu T Mohanty, Shruti Shah, Gholamreza Haffari, Jiake Xu, Matthew T Gillespie, Michael J Rogers, John T Price, Peter I Croucher, Julian MW Quinn

Journal article  |  2017  |  Oncotarget

Melphalan modifies the bone microenvironment by enhancing osteoclast formation.

Ryan C Chai, Michelle M McDonald, Rachael L Terry, Nataša Kovačić, Jenny M Down, Jessica A Pettitt, Sindhu T Mohanty, Shruti Shah, Gholamreza Haffari, Jiake Xu, Matthew T Gillespie, Michael J Rogers, John T Price, Peter I Croucher, Julian MW Quinn

Journal article  |  2017  |  Oncotarget

Melphalan is a cytotoxic chemotherapy used to treat patients with multiple myeloma (MM). Bone resorption by osteoclasts, by remode..

Histone deacetylase activity mediates acquired resistance towards structurally diverse HSP90 inhibitors

Ryan C Chai, Jessica L Vieusseux, Benjamin J Lang, Chau H Nguyen, Michelle M Kouspou, Kara L Britt, John T Price

Journal article  |  2017  |  Molecular Oncology

Osteoclast inhibitory lectin (OCIL) inhibits osteoblast differentiation and function in vitro

Akira Nakamura, Chi Ly, Mirijana Cipetic, Natalie A Sims, Jessica Vieusseux, Vicky Kartsogiannis, Stellos Bouralexis, Hasnawati Saleh, Hong Zhou, John T Price, I John Martin, Ko Wah Ng ng, Matthew T Gillespie, Julian MW Quinn

Journal article  |  2007  |  Bone

The heat shock protein 90 inhibitor, 17-allylamino-17-demethoxygeldanamycin, enhances osteoclast formation and potentiates bone metastasis of a human breast cancer cell line

JT Price, JMW Quinn, NA Sims, J Vieusseux, K Waldeck, SE Docherty, D Myers, A Nakamura, MC Waltham, MT Gillespie, EW Thompson

Journal article  |  2005  |  Cancer Research